← Leaderboards
Steven T Dekosky
Rush University Medical Center
$39,621,203
Attributed
$39,621,203
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.4M · FY2005–12$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$57,275,401 · 11
By mechanism
U01$30,587,782 · 1
P50$19,264,687 · 3
P01$7,350,735 · 6
P51$72,197 · 1
Top collaborators
No co-investigators on record.
Most similar at Rush University Medical Center
Same institution · by research overlap
- Elliott Jay Mufson$26,194,959
- Lester Irvin Binder$7,566,046
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposClinical ResearchS DiseaseAlzheimer'S DiseaseDementiaMild Cognitive ImpairmentAmyloidBaseSynapsesIn VivoPathologyImageSeriesAmyloid Beta-ProteinMagnetic Resonance ImagingProgramsNeuropsychological TestsHuman Old Age (65+)Positron-Emission TomographyMethodologyStagingDiagnosisFollow-UpUniversities
Grant awards (62)
SYNAPTIC, CHOLINERGIC AND AMYLOID ALTERATIONS IN MILD COGNITIVE IMPAIRMENT$309,839
P01 · FY2012 · AG · contact PI
SYNAPTIC, CHOLINERGIC AND AMYLOID ALTERATIONS IN MILD COGNITIVE IMPAIRMENT$228,359
P01 · FY2011 · AG · contact PI
SYNAPTIC, CHOLINERGIC AND AMYLOID ALTERATIONS IN MILD COGNITIVE IMPAIRMENT$397,741
P01 · FY2010 · AG · contact PI
TBI, Amyloid Metabolism and Statin Therapy$147,257
P01 · FY2010 · NS · contact PI
CORE--CLINICAL$746,702
P50 · FY2009 · AG · contact PI
SYNAPTIC, CHOLINERGIC AND AMYLOID ALTERATIONS IN MILD COGNITIVE IMPAIRMENT$306,923
P01 · FY2009 · AG · contact PI
LONGITUDINAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$224,759
P01 · FY2009 · AG · contact PI
TBI, Amyloid Metabolism and Statin Therapy$148,745
P01 · FY2009 · NS · contact PI
CLINICAL CORE$123,596
P01 · FY2009 · AG · contact PI
CORE--CLINICAL$725,594
P50 · FY2008 · AG · contact PI
LONGITUDINAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$367,142
P01 · FY2008 · AG · contact PI
SYNAPTIC, CHOLINERGIC AND AMYLOID ALTERATIONS IN MILD COGNITIVE IMPAIRMENT$315,366
P01 · FY2008 · AG · contact PI
TBI, Amyloid Metabolism and Statin Therapy$148,747
P01 · FY2008 · NS · contact PI
CLINICAL CORE$118,028
P01 · FY2008 · AG · contact PI
ALZHEIMER?S DISEASE RESEARCH CENTER$72,197
P51 · FY2008 · RR · contact PI
Ginkgo Biloba Prevention Trial in Older Individuals$4,003,900
U01 · FY2007 · AT · contact PI
Alzheimer's DIsease Research Center$2,023,516
P50 · FY2007 · AG · contact PI
In VivoPIB PET Amyloid Imaging: Normals, MCI & Dementia$1,085,718
P01 · FY2007 · AG · contact PI
CORE--CLINICAL$722,364
P50 · FY2007 · AG · contact PI
LONGITUDINAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$318,560
P01 · FY2007 · AG · contact PI
TBI, Amyloid Metabolism and Statin Therapy$153,201
P50 · FY2007 · NS · contact PI
CLINICAL CORE$102,100
P01 · FY2007 · AG · contact PI
Ginkgo Biloba Prevention Trial in Older Individuals$3,725,576
U01 · FY2006 · AT · contact PI
Alzheimer's DIsease Research Center$2,025,974
P50 · FY2006 · AG · contact PI
In VivoPIB PET Amyloid Imaging: Normals, MCI & Dementia$1,014,733
P01 · FY2006 · AG · contact PI
CORE--CLINICAL$429,332
P50 · FY2006 · AG · contact PI
CHOLINERGIC AND SYNAPTIC ALTERATIONS IN MILD COGNITIVE IMPAIRMENT$295,945
P01 · FY2006 · AG · contact PI
LONGITUDINAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$169,904
P01 · FY2006 · AG · contact PI
TBI, Amyloid Metabolism and Statin Therapy$157,150
P50 · FY2006 · NS · contact PI
CLINICAL CORE$62,180
P01 · FY2006 · AG · contact PI
Ginkgo Biloba Prevention Trial in Older Individuals$3,925,959
U01 · FY2005 · AT
Alzheimer's DIsease Research Center$1,997,680
P50 · FY2005 · AG
In VivoPIB PET Amyloid Imaging: Normals, MCI &Dementia$847,226
P01 · FY2005 · AG
CORE--CLINICAL$603,991
P50 · FY2005 · AG
LONGITUDINAL ASSESSMENT OF IN VIVO AMYLOID IN MCI AND AD$83,467
P01 · FY2005 · AG
CLINICAL CORE$58,753
P01 · FY2005 · AG
Alzheimer's DIsease Research Center$38,640
P50 · FY2005 · AG
GINKGO BILOBA PREVENTION TRIAL IN OLDER INDIVIDUALS$3,300,847
U01 · FY2004 · AT
ALZHEIMER DISEASE RESEARCH CENTER$1,865,110
P50 · FY2004 · AG
ALZHEIMER DISEASE RESEARCH CENTER$111,749
P50 · FY2004 · AG
ALZHEIMER DISEASE RESEARCH CENTER$2,000
P50 · FY2004 · AG
GINKGO BILOBA PREVENTION TRIAL IN OLDER INDIVIDUALS$3,600,000
U01 · FY2003 · AT
ALZHEIMER DISEASE RESEARCH CENTER$1,819,642
P50 · FY2003 · AG
GINKGO BILOBA PREVENTION TRIAL IN OLDER INDIVIDUALS$2,944,922
U01 · FY2002 · AT
ALZHEIMER DISEASE RESEARCH CENTER$1,496,245
P50 · FY2002 · AG
CHOLINERGIC AND SYNAPTIC ALTERATIONS IN MILD COGNITIVE IMPAIRMENT$299,423
P01 · FY2002 · AG
REGULATION OF APP AND A-BETA IN TBI$207,281
P50 · FY2002 · NS
CORE--CLINICAL$158,272
P50 · FY2002 · AG
ALZHEIMER DISEASE RESEARCH CENTER$149,500
P50 · FY2002 · AG
ADRC - Data Management Supplement$149,373
P50 · FY2002 · AG
ADRC Imaging Core Supplement$144,689
P50 · FY2002 · AG
GINKGO BILOBA PREVENTION TRIAL IN OLDER INDIVIDUALS$6,558,676
U01 · FY2001 · AT
ALZHEIMER DISEASE RESEARCH CENTER$1,457,956
P50 · FY2001 · AG
REGULATION OF APP AND A-BETA IN TBI$207,281
P50 · FY2001 · NS
CORE--CLINICAL$158,272
P50 · FY2001 · AG
REGULATION OF APP AND A-BETA IN TBI$65,227
P50 · FY2001 · NS
SYNAPTIC ABNORMALITIES AND MILD COGNITIVE IMPAIRMENT IN THE ELDERLY$0
P01 · FY2001 · AG
GINKGO BILOBA PREVENTION TRIAL IN OLDER INDIVIDUALS$2,527,902
U01 · FY2000 · AT
ALZHEIMER DISEASE RESEARCH CENTER$1,424,447
P50 · FY2000 · AG
SYNAPTIC ABNORMALITIES AND MILD COGNITIVE IMPAIRMENT IN THE ELDERLY$176,224
P01 · FY2000 · AG
CORE--CLINICAL$158,272
P50 · FY2000 · AG
REGULATION OF APP AND A-BETA IN TBI$65,227
P50 · FY2000 · NS